Kidney Care GPO 'ShenXieYiGou' Debuts, Revolutionizing Procurement for Independent Hemodialysis Centers and Boosting Private Nephrology Sector

Hemodialysis centers have remained a hotbed for medical investment in recent years, characterized by rapid market growth and immense potential. However, small and medium-sized private nephrology practices face numerous bottlenecks in establishing a foothold in this market due to their limited resources and influence.

VCBeat (WeChat ID: vcbeat) has learned that a new Group Purchasing Organization (GPO) model has emerged in the nephrology distribution channel, presenting significant opportunities for small and medium-sized private nephrology practices and upstream suppliers.

Recently, the 4th Summit Forum on Innovative Development of Nephrology and Dialysis of the Chinese Non-Public Medical Institutions Association and the 2018 Anhui Blood Purification Forum, hosted by the Chinese Non-Public Medical Institutions Association and its Professional Committee on Nephrology and Dialysis, were grandly held in Hefei, Anhui Province.

The 4th Summit Forum on Innovative Development in Nephrology and Dialysis & 2018 Anhui Blood Purification Forum

Nearly 100 private nephrology medical institutions across China, including Aishen Medical, Shenzhen Bailun Dialysis, and Guangdong Yangke Renal Dialysis, attended this high-level summit.

At this forum,Third-Party Private Nephrology GPO—Shenxie Yigou Makes Its Debut, and a grand launch ceremony was held. Li Chengxun, Vice President of Shenxie Yigou, joined Liu Wei, Chairman of Bailun Dialysis; Weng Jiajin, Chairman of Guangdong Yangke; Jie Renxiang, General Manager of Aishen Medical; and Zhang Cunming, Sales Director of Weigao Blood Purification, in jointly participating in the launch ceremony.

Dialysis centers have remained a hot spot for healthcare investment in recent years. The issuance of Document No. 67 in 2016 marked an unprecedented level of national support for the hemodialysis industry, from both patient and industrial perspectives, ushering in a golden era of development for the hemodialysis sector.

The state encourages dialysis centers to develop along the lines of chain operations and group-based models, and to open up to private capital. Since 2010, with the expansion of medical insurance coverage, the number of dialysis patients has been growing at a compound annual growth rate of nearly 15%–20%.

Currently, the market size of hemodialysis in China is approximately 22.5 billion yuan. If all 2 million patients with end-stage renal disease (ESRD) undergo hemodialysis treatment, with an annual treatment cost of 75,000 yuan per patient, the theoretical market space for hemodialysis centers would reach 150 billion yuan.There is nearly fivefold room for market growth.

Furthermore, China faces a shortage of dialysis beds, while market demand for treatment remains robust. Dialysis centers benefit from a stable patient base, standardized pricing, and a consistent treatment frequency of two to three sessions per week. Compared with other healthcare investments, dialysis centers offer stable cash flows and returns, with the added advantage of being scalable through replication and chain operations. These advantages have attracted significant investment into dialysis centers.

However, the third-party dialysis industry has long been plagued by pain points such as insufficient management experience, talent shortages, small scale with high marginal costs, and weak bargaining power. For new private nephrology medical institutions to achieve operational success, they must accomplish the following four objectives:

● Ensure safety and quality, and enhance service standards

● Procure cost-effective pharmaceuticals and medical consumables

● Reduce suppliers and focus on core product optimization

● Reduce inventory while maintaining optimal total cost

Contemporary small and medium-sized private nephrology practices require a grand alliance that can both reduce procurement costs and enhance procurement efficiency, while also leveraging financial leasing to alleviate the capital pressures associated with rapid expansion, thereby harnessing collective industry strength to secure greater bargaining power.

In response to the challenges, needs, and calls for action faced by private nephrology medical institutions in procurement, the “Kidney Device Easy-Buy Procurement Alliance”—China’s Private Nephrology Procurement Group Purchasing Organization (GPO)—was established.

GPO, short for Group Purchasing Organizations, is known in Chinese as centralized procurement organizations. GPOs negotiate with upstream suppliers to secure lower purchase prices through large-scale consolidated procurement, thereby helping downstream entities reduce costs and improve efficiency.

Renal Medical Equipment Easy Procurement Alliance (GPO) was initiated by several non-public medical institutions in China that were among the earliest to develop chain nephrology services, with the aim of enhancing bargaining power and optimizing procurement for private nephrology medical institutions within the alliance.

1. Cost Reduction and Efficiency Improvement

Renal Medical Device Easy Procurement Alliance (GPO) consolidates purchase orders from members of the private nephrology alliance to negotiate with suppliers for preferential pricing through bulk ordering.

2. Provide equipment financial leasing services

Shenxie Finance Launches Equipment Financial Leasing Program: Targeting Small and Medium-Sized Private Nephrology Enterprises Facing Capital Pressure for Large-Scale Equipment Procurement, the program leverages third-party financial support to alleviate short-term liquidity constraints and facilitate rapid growth. Through a streamlined five-step process—submission of materials, approval, contract signing, equipment delivery, and monthly repayments—eligible enterprises can access equipment financial leasing solutions to accelerate their development.

3. Nephrology Physician Group

Amid the rapid expansion of dialysis centers and severe staffing shortages, private nephrology practices seek to enhance patient service and retention by partnering with renowned experts from top-tier tertiary hospitals in China. Through remote consultations, remote ward rounds, as well as on-site visits and ward rounds, these experts help private nephrology practices improve their medical technical services while better attracting and retaining patients. Shenxie Yigou empowers the development of private nephrology physician groups, providing essential platform support for the rapid expansion of its alliance members.

4. Offline Services, Online E-commerce

The Renal Equipment EasyBuy Procurement Alliance (GPO) has become a supply chain service platform favored by many emerging private nephrology healthcare institutions. By adopting an innovative “offline services + online e-commerce” operational model, it provides alliance members—particularly group-affiliated chain providers in the private nephrology sector—with a one-stop procurement platform for dialysis and non-dialysis equipment and consumables, helping them reduce costs and improve efficiency.

(Compared with traditional distribution channels,GPOmore efficient format)

Image source: Li Hao, Procurement and Supply Chain Management for Chain Hemodialysis Centers

Benefits for Upstream Renal Device Manufacturers:Upstream players no longer need to negotiate with hospitals individually or sign contracts one by one; instead, they can leverage the scale effects of Group Purchasing Organizations (GPOs) to expand downstream coverage and conduct large-scale sales.

Benefits for Downstream Dialysis Centers:Join the Shenxie Yigou Group Purchasing Organization (GPO) to save time and money by outsourcing negotiations and contracting to Shenxie Yigou, allowing you to focus on healthcare management and patient services, thereby building core competitive advantages and brand equity.

According to representatives from Shenxie Yigou, the products currently available through the Shenxie Yigou Procurement Alliance GPO cover both dialysis and non-dialysis categories. Well-known brands include Fresenius, Toray, Weigao, Tascom, Medica, JMS, Mindray, Xinhua, and Philips, among others. More brands continue to join the platform.

“GPOs have been implemented in the United States for decades. In China, GPOs for public hospitals are government-led, but their rollout has faced challenges, primarily due to difficulties in coordinating the interests of multiple stakeholders. The launch of a private-sector nephrology GPO by Shenxie Yigou represents a market trend. We are willing to align with this trend by joining the Shenxie Yigou Procurement Alliance to enhance our market share and coverage,” stated Zhang Cunming, Director at Weigao Blood Purification, during the Innovation Development Summit.

The mature development of Group Purchasing Organizations (GPOs) in the United States foreshadows and underscores that the growth and expansion of the Kidney Device Easy-Procurement GPO Alliance in China is not only entirely feasible but also follows a predictable pattern, representing a highly favorable new model for independent hemodialysis centers.

For upstream manufacturers, supply channels and models are bound to undergo significant transformation, with greater emphasis placed on product R&D, production, and cost control; for investors, medical institutions that offer scalable, cost-controllable, and rapidly replicable models may be more favored.

In this new era, trends reign supreme. We are entering an age of comprehensive supply chain integration spanning R&D and manufacturing, distribution, and consumption. It is foreseeable that as more dialysis centers join the alliance, their collective bargaining power will command significant attention from manufacturers. We believe that the Shenxie Yigou Procurement Alliance (GPO) will substantially promote the healthy development of the private nephrology sector in the near future.